FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dick De Zeeuw

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Physiology

Glomerular Filtration Rate

Living Beings

Concepts & Ideas

Risk Factors

Phenomena

Renal Circulation

Co-author Network

Publications

TOP 3
Hiddo J Lambers Heerspink; Dick De Zeeuw
Dual RAAS blockade has dual effects on outcome.
S S Roscioni; Peter Rossing; Petra Zürbig; Stephan J.L. Bakker; Dick De Zeeuw; Ron T Gansevoort; Merel Elise Hellemons; Maria Lajer; H Mischak; Frederik Persson; H Reinhard; H J Lambers Heerspink
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.
Dick De Zeeuw; Melissa Krauth; Hiddo J Lambers Heerspink; John J McMurray; Colin J Meyer; Hans-Henrik Parving; Pablo E Pergola; Giuseppe Remuzzi; Robert D Toto; Nosratola D Vaziri; Christoph Wanner; David G Warnock; Janet Wittes; Rajiv Agarwal; Tadao Akizawa; Paul Audhya; George L Bakris; Melanie Chin; Glenn M Chertow
Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dick De Zeeuw (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hiddo J Lambers Heerspink; Dick De Zeeuw
Dual RAAS blockade has dual effects on outcome.
Nature reviews. Endocrinology 2013;9(5):261-3.
2013: S S Roscioni; Peter Rossing; Petra Zürbig; Stephan J.L. Bakker; Dick De Zeeuw; Ron T Gansevoort; Merel Elise Hellemons; Maria Lajer; H Mischak; Frederik Persson; H Reinhard; H J Lambers Heerspink
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.
Diabetologia 2013;56(2):259-67.
2013: Dick De Zeeuw; Melissa Krauth; Hiddo J Lambers Heerspink; John J McMurray; Colin J Meyer; Hans-Henrik Parving; Pablo E Pergola; Giuseppe Remuzzi; Robert D Toto; Nosratola D Vaziri; Christoph Wanner; David G Warnock; Janet Wittes; Rajiv Agarwal; Tadao Akizawa; Paul Audhya; George L Bakris; Melanie Chin; Glenn M Chertow
Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
American journal of nephrology 2013;37(3):212-22.
2012: Sara S Roscioni; Stephan J L Bakker; Dick De Zeeuw; Hiddo J Lambers Heerspink
Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.
Nature reviews. Nephrology 2012;8(12):691-9.
2012: Paul A Smink; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Hiddo J Lambers Heerspink; Dick De Zeeuw
Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;60(5):804-11.
2012: Hiddo J Lambers Heerspink; Pieter A de Graeff; Frank A Holtkamp; Julia B Lewis; gerjan navis; Hans-Henrik Parving; Eberhard Ritz; Dick De Zeeuw
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers.
Kidney international 2012;82(3):330-7.
2012: Ferdau L Nauta; Wim van Oeveren; Hiddo Lambers Heerspink; Stephan J L Bakker; Henk Bilo; Paul E de Jong; Dick De Zeeuw; Ron T Gansevoort
Effect of frozen storage on urinary concentration of kidney damage markers.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;59(4):586-9.
2012: Jarno Hoekman; Dick De Zeeuw; Koen Frenken; Hiddo Lambers Heerspink
The geographical distribution of leadership in globalized clinical trials.
PloS one 2012;7(10):e45984.
2012: Jaco Voorham; Bruce H R Wolffenbuttel; Dick De Zeeuw; Flora M Haaijer-Ruskamp; Ronald P Stolk; Petra Denig
Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study.
PloS one 2012;7(6):e38707.
2011: Liana Hakobyan; Dick De Zeeuw; Daniela Dobre; Flora M Haaijer-Ruskamp; Petra Denig
Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(12):1191-202.
2011: Sara S Roscioni; Hiddo J Lambers Heerspink; Dick De Zeeuw
Diabetes: ROADMAP: the road to renoprotection?
Nature reviews. Nephrology 2011;7(8):427-8.
2011: Dick De Zeeuw; Rulan S Parekh; Sandeep Soman
CKD treatment: time to alter the focus to albuminuria?
Advances in chronic kidney disease 2011;18(4):222-3.
2011: Yan Miao; Stefan A Ottenbros; Hans-Henrik Parving; Shahnaz Shahinfar; Barry M Brenner; Mark E Cooper; Dick De Zeeuw; Diederick E Grobbee; Goos D Laverman; Hiddo J Lambers Heerspink
Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.
Hypertension 2011;58(1):2-7.
2011: Frank A Holtkamp; Tom Berl; Pieter A de Graeff; Dick De Zeeuw; Gozewijn D Laverman; Julia B Lewis; David Packham; Hans-Henrik Parving; Giuseppe Remuzzi; Hiddo J Lambers Heerspink
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials.
European heart journal 2011;32(12):1493-9.
2011: Hiddo J Lambers Heerspink; Frank A Holtkamp; Dick De Zeeuw; Mordchai Ravid
Monitoring kidney function and albuminuria in patients with diabetes.
Diabetes care 2011;34 Suppl 2():S325-9.
2011: Hiddo J Lambers Heerspink; Dick De Zeeuw
ONTARGET still OFF-TARGET?
Circulation 2011;123(10):1049-51.
2011: Yan Miao; Paul A Smink; Dick De Zeeuw; Hiddo J Lambers Heerspink
Drug-induced changes in risk/biomarkers and their relationship with renal and cardiovascular long-term outcome in patients with diabetes.
Clinical chemistry 2011;57(2):186-95.
2011: Hiddo J Lambers Heerspink; Dick De Zeeuw
The kidney in type 2 diabetes therapy.
The review of diabetic studies : RDS 2011;8(3):392-402.
2011: Liana Hakobyan; Dick De Zeeuw; Daniela Dobre; Flora M Haaijer-Ruskamp; Petra Denig
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.
Health and quality of life outcomes 2011;9():83.
2011: Grigory Sidorenkov; Flora M Haaijer-Ruskamp; Dick De Zeeuw; Petra Denig
A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness.
PloS one 2011;6(9):e24278.
2011: Hiddo J Lambers Heerspink; Vlado Perkovic; Dick De Zeeuw
Is doubling of serum creatinine a valid clinical 'hard' endpoint in clinical nephrology trials?
Nephron. Clinical practice 2011;119(3):c195-9; discussion c199.
2011: Dick De Zeeuw
Unmet need in renal protection--do we need a more comprehensive approach?
Contributions to nephrology 2011;171():157-60.
2011: Y Miao; Daniela Dobre; H J Lambers Heerspink; Barry M Brenner; Mark E Cooper; Hans-Henrik Parving; Shahnaz Shahinfar; Diederick Grobbee; Dick De Zeeuw
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Diabetologia 2011;54(1):44-50.
2010: Akin Özyilmaz; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(11):3560-8.
2010: Hiddo J Lambers Heerspink; Ron T Gansevoort; Barry M Brenner; Mark E Cooper; Hans-Henrik Parving; Shahnaz Shahinfar; Dick De Zeeuw
Comparison of different measures of urinary protein excretion for prediction of renal events.
Journal of the American Society of Nephrology : JASN 2010;21(8):1355-60.
2010: Hiddo Lambers Heerspink; Dick De Zeeuw
Composite renal endpoints: was ACCOMPLISH accomplished?
Lancet 2010;375(9721):1140-2.
2010: Peter Ochodnický; Robert H Henning; Hendrik Buikema; Dick De Zeeuw; Abraham P Provoost; Richard P E van Dokkum
Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat.
American journal of physiology. Renal physiology 2010;298(3):F625-33.
2010: Hiddo J Lambers Heerspink; Dick De Zeeuw
Dual RAS therapy not on target, but fully alive.
Nephron. Clinical practice 2010;116(2):c137-42.
2010: Hiddo J Lambers Heerspink; Dick De Zeeuw
Debate: PRO position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?
American journal of nephrology 2010;31(5):458-61; discussion 468.
2010: Gerard C M Linssen; Stephan J L Bakker; Adriaan Voors; Ron T Gansevoort; Hans L Hillege; Paul E de Jong; Dirk J van Veldhuisen; Rijk O B Gans; Dick De Zeeuw
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.
European heart journal 2010;31(1):120-7.
2009: Hiddo J Lambers Heerspink; Vlado Perkovic; Dick De Zeeuw
Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
Journal of hypertension 2009;27(12):2321-31.
2009: Nynke Halbesma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
High protein intake associates with cardiovascular events but not with loss of renal function.
Journal of the American Society of Nephrology : JASN 2009;20(8):1797-804.
2009: Hiddo J Lambers Heerspink; F L Nauta; C P van der Zee; Jacoline W Brinkman; Ron T Gansevoort; Dick De Zeeuw; Stephan J.L. Bakker
Alkalinization of urine samples preserves albumin concentrations during prolonged frozen storage in patients with diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 2009;26(5):556-9.
2009: L S Wong; Willemijn A K M Windt; Anton J M Roks; Richard P E van Dokkum; Regien G Schoemaker; Dick De Zeeuw; Robert H Henning
Renal failure induces telomere shortening in the rat heart.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2009;17(5):190-4.
2009: Dick De Zeeuw; Hiddo Lambers-Heerspink
Drug dosing for renoprotection: maybe it's time for a drug efficacy-safety score?
Journal of the American Society of Nephrology : JASN 2009;20(4):688-9.
2009: Stephan J L Bakker; Ron T Gansevoort; Dick De Zeeuw
Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?
Current hypertension reports 2009;11(2):111-7.
2009: Marije van der Velde; Nynke Halbesma; Frank T de Charro; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Screening for albuminuria identifies individuals at increased renal risk.
Journal of the American Society of Nephrology : JASN 2009;20(4):852-62.
2009: Liffert Vogt; Dick De Zeeuw; Arend Jan J Woittiez; gerjan navis
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(4):1182-9.
2009: Daniela Dobre; Sandeep Nimade; Dick De Zeeuw
Albuminuria in heart failure: what do we really know?
Current opinion in cardiology 2009;24(2):148-54.
2009: Elsbeth C Witte; Hiddo J Lambers Heerspink; Dick De Zeeuw; Stephan J L Bakker; Paul E de Jong; Ronald Gansevoort
First morning voids are more reliable than spot urine samples to assess microalbuminuria.
Journal of the American Society of Nephrology : JASN 2009;20(2):436-43.
2009: Peter Ochodnicky; Robert H Henning; Hendrik Buikema; Alex C A Kluppel; Marjolein van Wattum; Dick De Zeeuw; Richard P E van Dokkum
Renal endothelial function and blood flow predict the individual susceptibility to adriamycin-induced renal damage.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(2):413-20.
2009: Hiddo J Lambers Heerspink; R Agarwal; D W Coyne; Hans-Henrik Parving; E Ritz; Giuseppe Remuzzi; P Audhya; M J Amdahl; D L Andress; Dick De Zeeuw
The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.
American journal of nephrology 2009;30(3):280-6.
2008: Hiddo J Lambers Heerspink; Mirjam J Knol; Robert J W Tijssen; Thed N van Leeuwen; Diederick Grobbee; Dick De Zeeuw
Is the randomized controlled drug trial in Europe lagging behind the USA?
British journal of clinical pharmacology 2008;66(6):774-80.
2008: Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(12):3851-8.
2008: Hiddo J Lambers Heerspink; Auke H Brantsma; Dick De Zeeuw; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort
Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality.
American journal of epidemiology 2008;168(8):897-905.
2008: Hiddo J Lambers Heerspink; Daniela Dobre; Hans L Hillege; Diederick Grobbee; Dick De Zeeuw
Does the European clinical trials directive really improve clinical trial approval time?
British journal of clinical pharmacology 2008;66(4):546-50.
2008: Willemijn A K M Windt; Robert H Henning; Alex C A Kluppel; Ying Xu; Dick De Zeeuw; Richard P E van Dokkum
Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(10):3103-10.
2008: Aminu K Bello; Jean Peters; Jeremy Wight; Dick De Zeeuw; Meguid El Nahas
A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(3):434-43.
2008: Auke H Brantsma; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Extended prognostic value of urinary albumin excretion for cardiovascular events.
Journal of the American Society of Nephrology : JASN 2008;19(9):1785-91.
2008: Nynke Halbesma; Auke H Brantsma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Gender differences in predictors of the decline of renal function in the general population.
Kidney international 2008;74(4):505-12.
2008: Hiddo J Lambers Heerspink; Elsbeth C Witte; Stephan J L Bakker; Paul E de Jong; Dick De Zeeuw; Ron T Gansevoort
Screening and monitoring for albuminuria: the performance of the HemoCue point-of-care system.
Kidney international 2008;74(3):377-83.
2008: Dick De Zeeuw
Renal disease: a common and a silent killer.
Nature clinical practice. Cardiovascular medicine 2008;5 Suppl 1():S27-35.
2008: Dick De Zeeuw; Stephan J.L. Bakker
Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?
Nature clinical practice. Cardiovascular medicine 2008;5 Suppl 1():S10-4.
2008: Maria Sandovici; Robert H Henning; Harry van Goor; Wijnand Helfrich; Dick De Zeeuw; Leo E Deelman
Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injury.
Kidney international 2008;73(12):1364-73.
2008: Maria Sandovici; Leo E Deelman; Dick De Zeeuw; Harry van Goor; Robert H Henning
Immune modulation and graft protection by gene therapy in kidney transplantation.
European journal of pharmacology 2008;585(2-3):261-9.
2008: Liffert Vogt; Femke Waanders; Frans Boomsma; Dick De Zeeuw; gerjan navis
Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.
Journal of the American Society of Nephrology : JASN 2008;19(5):999-1007.
2008: Willemijn A K M Windt; Richard P E van Dokkum; C Alex Kluppel; C Margot Jeronimus-Stratingh; Florian Hut; Dick De Zeeuw; Robert H Henning
Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
European journal of pharmacology 2008;580(1-2):231-40.
2008: Dick De Zeeuw; Itamar Raz
Albuminuria: a great risk marker, but an underestimated target in diabetes.
Diabetes care 2008;31 Suppl 2():S190-3.
2008: A Titia Lely; Frank G H van Der Kleij; Taco J Kistemaker; Alfred J Apperloo; Paul E de Jong; Dick De Zeeuw; gerjan navis
Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(1):54-60.
2007: Maria Sandovici; Leo E Deelman; Harry van Goor; Wijnand Helfrich; Dick De Zeeuw; Robert H Henning
Adenovirus-mediated interleukin-13 gene therapy attenuates acute kidney allograft injury.
The journal of gene medicine 2007;9(12):1024-32.
2007: Adrienne A M Zandbergen; Liffert Vogt; Dick De Zeeuw; Steven W J Lamberts; Rob J T H Ouwendijk; Marinus G A Baggen; Aart H Bootsma
Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria.
Diabetes care 2007;30(12):3119-21.
2007: Jacoline W Brinkman; Hiddo Lambers Heerspink; Dick De Zeeuw; Ron T Gansevoort; Stephan J L Bakker
Urinary pH affects albumin concentrations after prolonged frozen storage.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(12):3670.
2007: Jacoline W Brinkman; Dick De Zeeuw; Hiddo J Lambers Heerspink; Ron T Gansevoort; Ido P Kema; Paul E de Jong; Stephan J L Bakker
Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry.
Clinical chemistry 2007;53(8):1520-6.
2007: Wouter B A Eijkelkamp; Pieter A de Graeff; Dirk J van Veldhuisen; Richard P E van Dokkum; Ron T Gansevoort; Paul E de Jong; Dick De Zeeuw; Hans L Hillege
Effect of first myocardial ischemic event on renal function.
The American journal of cardiology 2007;100(1):7-12.
2007: Aminu K Bello; Dick De Zeeuw; Meguid El Nahas; Auke H Brantsma; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort
Impact of weight change on albuminuria in the general population.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1619-27.
2007: Wouter B A Eijkelkamp; Zhongxin Zhang; Giuseppe Remuzzi; Hans-Henrik Parving; Mark E Cooper; William F Keane; Shahnaz Shahinfar; Gilbert W Gleim; Matthew R Weir; Barry M Brenner; Dick De Zeeuw
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Journal of the American Society of Nephrology : JASN 2007;18(5):1540-6.
2007: Wouter B A Eijkelkamp; Zhongxin Zhang; Barry M Brenner; Mark E Cooper; Richard B Devereux; Björn Dahlöf; Hans Ibsen; William F Keane; Lars H Lindholm; Michael H Olsen; Hans-Henrik Parving; Giuseppe Remuzzi; Shahnaz Shahinfar; Steven M Snapinn; Kristian Wachtell; Dick De Zeeuw
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies.
Journal of hypertension 2007;25(4):871-6.
2007: Dick De Zeeuw
Albuminuria: a target for treatment of type 2 diabetic nephropathy.
Seminars in nephrology 2007;27(2):172-81.
2007: Jacoba P Greving; Petra Denig; Dick De Zeeuw; Flora M Haaijer-Ruskamp
Claims in advertisements for antihypertensive drugs in a Dutch medical journal.
Journal of hypertension 2007;25(3):713-22.
2007: Auke H Brantsma; Jarir Atthobari; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
What predicts progression and regression of urinary albumin excretion in the nondiabetic population?
Journal of the American Society of Nephrology : JASN 2007;18(2):637-45.
2007: Jacoba P Greving; Petra Denig; Dick De Zeeuw; Henk J G Bilo; Flora M Haaijer-Ruskamp
Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study.
Cardiovascular diabetology 2007;6():25.
2007: Jacoline W Brinkman; Dick De Zeeuw; Ron T Gansevoort; Jacko J Duker; Ido P Kema; Paul E de Jong; Stephan J L Bakker
Prolonged frozen storage of urine reduces the value of albuminuria for mortality prediction.
Clinical chemistry 2007;53(1):153-4.
2007: Stephan J L Bakker; Ron T Gansevoort; Dick De Zeeuw
Metabolic syndrome: a fata morgana?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):15-20.
2006: Willemijn A K M Windt; Atsua Tahara; Alex C A Kluppel; Dick De Zeeuw; Robert H Henning; Richard P E van Dokkum
Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2006;7(4):217-24.
2006: Simone Vettoretti; Peter Ochodnicky; Hendrik Buikema; Robert H Henning; C Alex Kluppel; Dick De Zeeuw; Richard P E van Dokkum
Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats.
Journal of hypertension 2006;24(11):2215-23.
2006: Hiddo J Lambers Heerspink; Jacoline W Brinkman; Stephan J L Bakker; Ron T Gansevoort; Dick De Zeeuw
Update on microalbuminuria as a biomarker in renal and cardiovascular disease.
Current opinion in nephrology and hypertension 2006;15(6):631-6.
2006: Willemijn A K M Windt; Wouter B A Eijkelkamp; Robert H Henning; Alex C A Kluppel; Pieter A de Graeff; Hans L Hillege; Stefan Schäfer; Dick De Zeeuw; Richard P E van Dokkum
Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention.
Journal of the American Society of Nephrology : JASN 2006;17(11):3059-66.
2006: Ron T Gansevoort; Jacoline W Brinkman; Stephan J L Bakker; Paul E de Jong; Dick De Zeeuw
Evaluation of measures of urinary albumin excretion.
American journal of epidemiology 2006;164(8):725-7.
2006: Els A Van der Wouden; Peter Ochodnický; Richard P E van Dokkum; Anton J M Roks; Leo E Deelman; Dick De Zeeuw; Robert H Henning
The role of angiotensin(1-7) in renal vasculature of the rat.
Journal of hypertension 2006;24(10):1971-8.
2006: Nynke Halbesma; Dirk-Sjoerd Kuiken; Auke H Brantsma; Stephan J L Bakker; Jack F M Wetzels; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
Journal of the American Society of Nephrology : JASN 2006;17(9):2582-90.
2006: Dick De Zeeuw; Hans-Henrik Parving; Robert H Henning
Microalbuminuria as an early marker for cardiovascular disease.
Journal of the American Society of Nephrology : JASN 2006;17(8):2100-5.
2006: William F Keane; Zhongxin Zhang; Paulette A Lyle; Mark E Cooper; Dick De Zeeuw; Jean-Pierre Grunfeld; James P Lash; Janet B McGill; William E Mitch; Giuseppe Remuzzi; Shahnaz Shahinfar; Steven M Snapinn; Robert D Toto; Barry M Brenner
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(4):761-7.
2006: Peter Ochodnicky; Simone Vettoretti; Robert H Henning; Hendrik Buikema; Richard P E van Dokkum; Dick De Zeeuw
Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
Journal of nephrology 2006;19(3):246-58.
2006: Dick De Zeeuw; Denise Ramjit; Zhongxin Zhang; Artur B Ribeiro; K Kurokawa; James P Lash; J Chan; Giuseppe Remuzzi; Barry M Brenner; Shahnaz Shahinfar
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL.
Kidney international 2006;69(9):1675-82.
2006: Peter Ochodnický; Dick De Zeeuw; Robert H Henning; C Alex Kluppel; Richard P E van Dokkum
Endothelial function predicts the development of renal damage after combined nephrectomy and myocardial infarction.
Journal of the American Society of Nephrology : JASN 2006;17(4 Suppl 2):S49-52.
2006: Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; john mcmurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick De Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Circulation 2006;113(5):671-8.
2006: Auke H Brantsma; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Urinary albumin excretion as a predictor of the development of hypertension in the general population.
Journal of the American Society of Nephrology : JASN 2006;17(2):331-5.
2006: Jacoba P Greving; Petra Denig; Dick De Zeeuw; Flora M Haaijer-Ruskamp
Physicians' attitudes towards treatment guidelines: differences between teaching and nonteaching hospitals.
European journal of clinical pharmacology 2006;62(2):129-33.
2006: Peter Ochodnicky; Robert H Henning; Richard P E van Dokkum; Dick De Zeeuw
Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage.
Journal of cardiovascular pharmacology 2006;47 Suppl 2():S151-62; discussion S172-6.
2006: Cornelis Boersma; Jarir Atthobari; Ron T Gansevoort; Lolkje T W de Jong van den Berg; Paul E de Jong; Dick De Zeeuw; Lieven J P Annemans; Maarten J Postma
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.
PharmacoEconomics 2006;24(6):523-35.
2006: Maria Sandovici; Leo E Deelman; Annemieke Smit-van Oosten; Harry van Goor; Marianne G Rots; Dick De Zeeuw; Robert H Henning
Enhanced transduction of fibroblasts in transplanted kidney with an adenovirus having an RGD motif in the HI loop.
Kidney international 2006;69(1):45-52.
2005: Bart Westendorp; Regien G Schoemaker; Hendrik Buikema; Dick De Zeeuw; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen
Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril.
European journal of heart failure 2005;7(7):1085-94.
2005: Jacoline W Brinkman; Dick De Zeeuw; Jacko J Duker; Ron T Gansevoort; Ido P Kema; Hans L Hillege; Paul E de Jong; Stephan J L Bakker
Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples.
Clinical chemistry 2005;51(11):2181-3.
2005: Liffert Vogt; gerjan navis; Jürgen Köster; Athanasios J Manolis; John L Reid; Dick De Zeeuw
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
Journal of hypertension 2005;23(11):2055-61.
2005: Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.
Diabetes care 2005;28(10):2525-30.
2005: Stephan J L Bakker; Ron T Gansevoort; Erik M Stuveling; Rijk O B Gans; Dick De Zeeuw
Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?
Current hypertension reports 2005;7(5):379-84.
2005: Geoffrey Boner; Mark E Cooper; K McCarroll; Barry M Brenner; Dick De Zeeuw; Peter R Kowey; Shahnaz Shahinfar; Tania Z Dickson; R S Crow; H-H Parving
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.
Diabetologia 2005;48(10):1980-7.
2005: Els A Van der Wouden; Robert H Henning; Leo E Deelman; Anton J M Roks; Frans Boomsma; Dick De Zeeuw
Does angiotensin (1-7) contribute to the anti-proteinuric effect of ACE-inhibitors.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2005;6(2):96-101.
2005: Dick De Zeeuw; Hans L Hillege; Paul E de Jong
The kidney, a cardiovascular risk marker, and a new target for therapy.
Kidney international. Supplement 2005;(98):S25-9.
2005: John H Dirks; Dick De Zeeuw; Sanjay K Agarwal; Robert C Atkins; Ricardo Correa-Rotter; Giuseppe D'Amico; Peter H Bennett; Meguid El Nahas; Raul Herrera Valdes; Dan Kaseje; Ivor J Katz; Sarala Naicker; Bernardo Rodriguez-Iturbe; Arrigo Schieppati; Faissal Shaheen; Chitr Sitthi-Amorn; Kim Solez; Giancarlo Viberti; Giuseppe Remuzzi; Jan J Weening
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration.
Kidney international. Supplement 2005;(98):S1-6.
2005: Jacoba P Greving; Petra Denig; Willem Jan van der Veen; Frank W Beltman; Miriam C J M Sturkenboom; Dick De Zeeuw; Flora M Haaijer-Ruskamp
Uptake of angiotensin II receptor blockers in the treatment of hypertension.
European journal of clinical pharmacology 2005;61(5-6):461-6.
2005: Zhongxin Zhang; Shahnaz Shahinfar; William F Keane; Denise Ramjit; Tania Z Dickson; Gilbert W Gleim; Carl Erik Mogensen; Dick De Zeeuw; Barry M Brenner; Steven M Snapinn
Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.
Journal of the American Society of Nephrology : JASN 2005;16(6):1775-80.
2005: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
The association between atherosclerotic risk factors and renal function in the general population.
Kidney international 2005;67(5):1967-73.
2005: Gozewijn D Laverman; Steen Andersen; Peter Rossing; gerjan navis; Dick De Zeeuw; Hans-Henrik Parving
Renoprotection with and without blood pressure reduction.
Kidney international. Supplement 2005;(94):S54-9.
2005: Ron T Gansevoort; Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population.
Kidney international. Supplement 2005;(94):S28-35.
2005: Paul E de Jong; Dick De Zeeuw
Renoprotective therapy: is it blood pressure or albuminuria that matters?
Lancet 2005;365(9463):913-4.
2005: Liffert Vogt; gerjan navis; Dick De Zeeuw
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?
Journal of the American Society of Nephrology : JASN 2005;16 Suppl 1():S53-7.
2005: Auke H Brantsma; Dick De Zeeuw; Hans L Hillege
Letter regarding article by Klausen et al, "very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes".
Circulation 2005;111(8):e110-1; author reply e110-1.
2005: Erik M Stuveling; Stephan J L Bakker; Hans L Hillege; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(3):497-508.
2004: Willemijn A K M Windt; Jai Prakash; Robbert J Kok; Frits Moolenaar; C Alex Kluppel; Dick De Zeeuw; Richard P E van Dokkum; Robert H Henning
Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(4):197-202.
2004: Anton J M Roks; Jeroen Nijholt; Azuwerus van Buiten; Wiek H van Gilst; Dick De Zeeuw; Robert H Henning
Low sodium diet inhibits the local counter-regulator effect of angiotensin-(1-7) on angiotensin II.
Journal of hypertension 2004;22(12):2355-61.
2004: Richard P E van Dokkum; Wouter B A Eijkelkamp; Alex C A Kluppel; Robert H Henning; Harry van Goor; Marin Citgez; Willemijn A K M Windt; Dirk J van Veldhuisen; Pieter A de Graeff; Dick De Zeeuw
Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction.
Journal of the American Society of Nephrology : JASN 2004;15(12):3103-10.
2004: Folkert Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick De Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Circulation 2004;110(18):2809-16.
2004: Dick De Zeeuw
Should albuminuria be a therapeutic target in patients with hypertension and diabetes?
American journal of hypertension 2004;17(11 Pt 2):11S-15S; quiz A2-4.
2004: P A Marcel de Vries; Dick De Zeeuw; Paul E de Jong; gerjan navis
The abnormal renal vasodilator response to D1-like receptor stimulation in conscious SHR can be normalized by AT1 blockade.
Journal of cardiovascular pharmacology 2004;44(5):571-6.
2004: William E Mitch; Shahnaz Shahinfar; Tania Z Dickson; Dick De Zeeuw; Zhongxin Zhang
Detecting and managing patients with type 2 diabetic kidney disease: proteinuria and cardiovascular disease.
Kidney international. Supplement 2004;(92):S97-8.
2004: Ron T Gansevoort; Bart van der Heij; Coen A Stegeman; Frank T de Charro; Martin G Nieuwenhuizen; Dick De Zeeuw; Paul E de Jong
Trends in the incidence of treated end-stage renal failure in The Netherlands: hope for the future?
Kidney international. Supplement 2004;(92):S7-10.
2004: Jacoline W Brinkman; Stephan J L Bakker; Ron T Gansevoort; Hans L Hillege; Ido P Kema; Rijk O B Gans; Paul E de Jong; Dick De Zeeuw
Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC.
Kidney international. Supplement 2004;(92):S69-75.
2004: Dick De Zeeuw
Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?
Kidney international. Supplement 2004;(92):S2-6.
2004: Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong
An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.
Kidney international. Supplement 2004;(92):S18-21.
2004: Jacoba P Greving; Petra Denig; Willem Jan van der Veen; Frank W Beltman; Miriam C J M Sturkenboom; Dick De Zeeuw; Flora M Haaijer-Ruskamp
Does comorbidity explain trends in prescribing of newer antihypertensive agents?
Journal of hypertension 2004;22(11):2209-15.
2004: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Wilbert M T Janssen; Ron T Gansevoort; gerjan navis; Dick De Zeeuw; Paul E de Jong
Sodium intake affects urinary albumin excretion especially in overweight subjects.
Journal of internal medicine 2004;256(4):324-30.
2004: Menno J A Kocks; Simone Gschwend; Dick De Zeeuw; gerjan navis; Hendrik Buikema
Low sodium modifies the vascular effects of angiotensin-converting enzyme inhibitor therapy in healthy rats.
The Journal of pharmacology and experimental therapeutics 2004;310(3):1183-9.
2004: Dick De Zeeuw; Giuseppe Remuzzi; Hans-Henrik Parving; William F Keane; Zhongxin Zhang; Shahnaz Shahinfar; Steven M Snapinn; Mark E Cooper; William E Mitch; Barry M Brenner
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
Circulation 2004;110(8):921-7.
2004: Els A Van der Wouden; Maria Sandovici; Robert H Henning; Dick De Zeeuw; Leo E Deelman
Approaches and methods in gene therapy for kidney disease.
Journal of pharmacological and toxicological methods 2004;50(1):13-24.
2004: Dick De Zeeuw; Giuseppe Remuzzi; Hans-Henrik Parving; William F Keane; Zhongxin Zhang; Shahnaz Shahinfar; Steven M Snapinn; Mark E Cooper; William E Mitch; Barry M Brenner
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
Kidney international 2004;65(6):2309-20.
2004: Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E de Jong
Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.
Journal of the American Society of Nephrology : JASN 2004;15(5):1316-22.
2004: Eric L Knight; Jacobien C Verhave; Donna Spiegelman; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E de Jong
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.
Kidney international 2004;65(4):1416-21.
2004: Erik M Stuveling; Stephan J L Bakker; Hans L Hillege; Johannes G M Burgerhof; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
C-reactive protein modifies the relationship between blood pressure and microalbuminuria.
Hypertension 2004;43(4):791-6.
2004: Bart Westendorp; Regien G Schoemaker; Hendrik Buikema; Dick De Zeeuw; Dirk J van Veldhuisen; Wiek H van Gilst
Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(1):27-32.
2004: Erik M Stuveling; Hans L Hillege; Stephan J L Bakker; Folkert Asselbergs; Paul E de Jong; Rijk O B Gans; Dick De Zeeuw
C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease.
Atherosclerosis 2004;172(1):107-14.
2003: Menno J A Kocks; Hendrik Buikema; Simone Gschwend; Frans Boomsma; Dick De Zeeuw; gerjan navis
High dietary sodium blunts affects of angiotensin-converting enzyme inhibition on vascular angiotensin I-to-angiotensin II conversion in rats.
Journal of cardiovascular pharmacology 2003;42(5):601-6.
2003: Sara-Joan Pinto-Sietsma; Stefan-Martin Herrmann; Klaus Schmidt-Petersen; Tianhua Niu; Hans L Hillege; Wilbert M T Janssen; Dick De Zeeuw; Paul de Jong; Reinhold Kreutz
Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population.
Journal of the American Society of Nephrology : JASN 2003;14(10):2596-602.
2003: Maarten J Postma; Hanneke Kruidhof; Lolkje T W de Jong van den Berg; Dick De Zeeuw
Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with Type 2 diabetes.
Expert opinion on pharmacotherapy 2003;4(9):1543-50.
2003: Simone Gschwend; Robert H Henning; Yigal M Pinto; Dick De Zeeuw; Wiek H van Gilst; Hendrik Buikema
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
British journal of pharmacology 2003;139(7):1317-25.
2003: Adrienne A M Zandbergen; Marinus G A Baggen; Steven W J Lamberts; Aart H Bootsma; Dick De Zeeuw; Rob J Th Ouwendijk
Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.
Annals of internal medicine 2003;139(2):90-6.
2003: Marijke Haas Jimoh Akanbi; Eric De Boer; Paul E de Jong; Frits Moolenaar; Dirk K F Meijer; Dick De Zeeuw
Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
Clinical science (London, England : 1979) 2003;105(1):51-7.
2003: Hendrik Bos; Gozewijn D Laverman; Robert H Henning; Anton T M G Tiebosch; Paul E de Jong; Dick De Zeeuw; gerjan navis
Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(2):106-12.
2003: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; gerjan navis; Dick De Zeeuw; Paul E de Jong
Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women.
Journal of the American Society of Nephrology : JASN 2003;14(5):1330-5.
2003: Jacobien C Verhave; Corine P Baljé-Volkers; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
The reliability of different formulae to predict creatinine clearance.
Journal of internal medicine 2003;253(5):563-73.
2003: Sara-Joan Pinto-Sietsma; gerjan navis; Wilbert M T Janssen; Dick De Zeeuw; Reinhold O B Gans; Paul E de Jong
A central body fat distribution is related to renal function impairment, even in lean subjects.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(4):733-41.
2003: Simone Gschwend; Robert H Henning; Dick De Zeeuw; Hendrik Buikema
Coronary myogenic constriction antagonizes EDHF-mediated dilation: role of KCa channels.
Hypertension 2003;41(4):912-8.
2003: William F Keane; Barry M Brenner; Dick De Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert D Toto
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.
Kidney international 2003;63(4):1499-507.
2003: Liffert Vogt; Gozewijn D Laverman; Dick De Zeeuw; gerjan navis
The COOPERATE trial.
Lancet 2003;361(9362):1055-6.
2003: Leo E Deelman; gerjan navis; Erik de Boer; Mirian Wietses; Dick De Zeeuw; Robert H Henning
Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric rats.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(1):38-42.
2003: Simone Gschwend; Hendrik Buikema; Robert H Henning; Yigal M Pinto; Dick De Zeeuw; Wiek H van Gilst
Endothelial dysfunction and infarct-size relate to impaired EDHF response in rat experimental chronic heart failure.
European journal of heart failure 2003;5(2):147-54.
2003: Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen; gerjan navis; Diederick Grobbee; Pieter A de Graeff; Dick De Zeeuw
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.
European heart journal 2003;24(5):412-20.
2003: Erik M Stuveling; Hans L Hillege; Stephan J L Bakker; Rijk O B Gans; Paul E de Jong; Dick De Zeeuw
C-reactive protein is associated with renal function abnormalities in a non-diabetic population.
Kidney international 2003;63(2):654-61.
2003: R G F Haverdings; Marijke Haas; G J Navis; Anne-miek Van Loenen-Weemaes; Dirk K F Meijer; Dick De Zeeuw; Frits Moolenaar
Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.
British journal of pharmacology 2003;138(4):531.
2003: Dick De Zeeuw
Best practice for hypertensive patients with kidney disease.
Hospital medicine (London, England : 1998) 2003;64(2):96-100.
2003: Paul E de Jong; Hans L Hillege; Sara-Joan Pinto-Sietsma; Dick De Zeeuw
Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(1):10-3.
2003: Gozewijn D Laverman; Harry van Goor; Robert H Henning; Paul E de Jong; Dick De Zeeuw; gerjan navis
Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes.
Kidney international 2003;63(1):64-71.
2002: Marijke Haas Jimoh Akanbi; Frits Moolenaar; Dirk K F Meijer; Dick De Zeeuw
Specific drug delivery to the kidney.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(6):489-96.
2002: Gozewijn D Laverman; Dick De Zeeuw; gerjan navis
Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?
Journal of the renin-angiotensin-aldosterone system : JRAAS 2002;3(4):205-13.
2002: Simone Gschwend; Hendrik Buikema; gerjan navis; Robert H Henning; Dick De Zeeuw; Richard P E van Dokkum
Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat.
Journal of the American Society of Nephrology : JASN 2002;13(12):2909-15.
2002: Liffert Vogt; gerjan navis; Dick De Zeeuw
Renoprotection: a matter of blood pressure reduction or agent-characteristics?
Journal of the American Society of Nephrology : JASN 2002;13 Suppl 3():S202-7.
2002: Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick De Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick Grobbee; Paul E de Jong
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Circulation 2002;106(14):1777-82.
2002: Gozewijn D Laverman; gerjan navis; Robert H Henning; Paul E de Jong; Dick De Zeeuw
Dual renin-angiotensin system blockade at optimal doses for proteinuria.
Kidney international 2002;62(3):1020-5.
2002: R Folgert G Haverdings; Marijke Haas; gerjan navis; Anne-miek Van Loenen-Weemaes; Dirk K F Meijer; Dick De Zeeuw; Frits Moolenaar
Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.
British journal of pharmacology 2002;136(8):1107-16.
2002: Jacobien C Verhave; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
How to measure the prevalence of microalbuminuria in relation to age and gender?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(2):436-7; author reply 437.
2002: Simone Gschwend; Sara-Joan Pinto-Sietsma; Hendrik Buikema; Yigal M Pinto; Wiek H van Gilst; Angela Schulz; Dick De Zeeuw; Reinhold Kreutz
Impaired coronary endothelial function in a rat model of spontaneous albuminuria.
Kidney international 2002;62(1):181-91.
2002: Robbert J Kok; R Folgert G Haverdings; F Grijpstra; J Koiter; Frits Moolenaar; Dick De Zeeuw; Dirk K F Meijer
Targeting of captopril to the kidney reduces renal angiotensin-converting enzyme activity without affecting systemic blood pressure.
The Journal of pharmacology and experimental therapeutics 2002;301(3):1139-43.
2002: Hendrik Bos; Robert H Henning; Paul E de Jong; Dick De Zeeuw; gerjan navis
Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(5):793-7.
2002: Frank G H van Der Kleij; Paul E de Jong; Robert H Henning; Dick De Zeeuw; gerjan navis
Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.
Journal of the American Society of Nephrology : JASN 2002;13(4):1025-33.
2002: Robert H Henning; Leo E Deelman; Roelof Hut; Eddy A Van der Zee; Hendrik Buikema; S Adriaan Nelemans; Harm Lip; Dick De Zeeuw; Serge Daan; Anne H Epema
Normalization of aortic function during arousal episodes in the hibernating ground squirrel.
Life sciences 2002;70(17):2071-83.
2002: Menno J A Kocks; Dick De Zeeuw; gerjan navis
Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease: the potential of exploring the mechanisms of response variability.
Current opinion in nephrology and hypertension 2002;11(2):135-40.
2002: Marijke Haas Jimoh Akanbi; Frits Moolenaar; Angela Elsinga; Els A Van der Wouden; Paul E de Jong; Dirk K F Meijer; Dick De Zeeuw
Targeting of doxorubicin to the urinary bladder of the rat shows increased cytotoxicity in the bladder urine combined with an absence of renal toxicity.
Journal of drug targeting 2002;10(1):81-9.
2002: Hendrik Bos; Robert H Henning; Eric De Boer; Anton T M G Tiebosch; Paul E de Jong; Dick De Zeeuw; gerjan navis
Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
Kidney international 2002;61(2):473-80.
2002: Hans Hillege; Wiek H van Gilst; Dick De Zeeuw; Dirk Jan van Veldhuisen
Renal function as a predictor of prognosis in chronic heart failure.
Heart failure monitor 2002;2(3):78-84.
2001: Catalin M Filipeanu; Robert H Henning; S Adriaan Nelemans; Dick De Zeeuw
Intracellular angiotensin II: from myth to reality?
Journal of the renin-angiotensin-aldosterone system : JRAAS 2001;2(4):219-26.
2001: Gozewijn D Laverman; Robert H Henning; Paul E de Jong; gerjan navis; Dick De Zeeuw
Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(6):1381-4.
2001: Catalin M Filipeanu; Eugen Brailoiu; Robert H Henning; Leo E Deelman; Dick De Zeeuw; S Adriaan Nelemans
Intracellular angiotensin II inhibits heterologous receptor stimulated Ca2+ entry.
Life sciences 2001;70(2):171-80.
2001: A Boonstra; Dick De Zeeuw; P E de Jong; gerjan navis
Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease.
Seminars in nephrology 2001;21(6):580-92.
2001: Barry M Brenner; M E Cooper; Dick De Zeeuw; William F Keane; W E Mitch; Hans-Henrik Parving; Giuseppe Remuzzi; Steven M Snapinn; Zhongxin Zhang; Shahnaz Shahinfar
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
The New England journal of medicine 2001;345(12):861-9.
2001: Arnold H Boonstra; Simone Gschwend; Menno J A Kocks; Hendrik Buikema; Dick De Zeeuw; gerjan navis
Does a low-salt diet exert a protective effect on endothelial function in normal rats?
The Journal of laboratory and clinical medicine 2001;138(3):200-5.
2001: Hans L Hillege; Wilbert M T Janssen; AA Bak; Gilles F H Diercks; Diederick Grobbee; Harry J G M Crijns; Wiek H van Gilst; Dick De Zeeuw; Paul E de Jong
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.
Journal of internal medicine 2001;249(6):519-26.
2001: Catalin M Filipeanu; Eugen Brailoiu; Jan Willem Kok; Robert H Henning; Dick De Zeeuw; S Adriaan Nelemans
Intracellular angiotensin II elicits Ca2+ increases in A7r5 vascular smooth muscle cells.
European journal of pharmacology 2001;420(1):9-18.
2001: R Folgert G Haverdings; Marijke Haas Jimoh Akanbi; A R Greupink; P A Marcel de Vries; Frits Moolenaar; Dick De Zeeuw; Dirk K F Meijer
Potentials and limitations of the low-molecular-weight protein lysozyme as a carrier for renal drug targeting.
Renal failure 2001;23(3-4):397-409.
2001: H Buter; gerjan navis; R P F Dullaart; Dick De Zeeuw; Paul E de Jong
Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(4):771-5.
2001: Catalin M Filipeanu; Robert H Henning; Dick De Zeeuw; Adriaan Nelemans
Intracellular Angiotensin II and cell growth of vascular smooth muscle cells.
British journal of pharmacology 2001;132(7):1590-6.
2000: Barry M Brenner; M E Cooper; Dick De Zeeuw; Jean-Pierre Grunfeld; William F Keane; K Kurokawa; J B McGill; W E Mitch; Hans-Henrik Parving; Giuseppe Remuzzi; Artur B Ribeiro; M D Schluchter; D Snavely; Zhongxin Zhang; R Simpson; Denise Ramjit; Shahnaz Shahinfar
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan).
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(4):328-35.
2000: Wilbert M T Janssen; Hans L Hillege; Sara-Joan Pinto-Sietsma; AA Bak; Dick De Zeeuw; Paul E de Jong
Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2000;38(11):1107-10.
2000: Sara-Joan Pinto-Sietsma; J Mulder; Wilbert M T Janssen; Hans L Hillege; Dick De Zeeuw; Paul E de Jong
Smoking is related to albuminuria and abnormal renal function in nondiabetic persons.
Annals of internal medicine 2000;133(8):585-91.
2000: Sara-Joan Pinto-Sietsma; Wilbert M T Janssen; Hans L Hillege; gerjan navis; Dick De Zeeuw; Paul E de Jong
Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population.
Journal of the American Society of Nephrology : JASN 2000;11(10):1882-8.
2000: P van Paassen; Dick De Zeeuw; Paul E de Jong; gerjan navis
Renin inhibition improves pressure natriuresis in essential hypertension.
Journal of the American Society of Nephrology : JASN 2000;11(10):1813-8.
2000: Hendrik Buikema; Stefan H J Monnink; René A Tio; Harry J G M Crijns; Dick De Zeeuw; Wiek H van Gilst
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
British journal of pharmacology 2000;130(8):1999-2007.
2000: Hans L Hillege; A R Girbes; Pieter J de Kam; Frans Boomsma; Dick De Zeeuw; Andrew Charlesworth; John R Hampton; Dirk J van Veldhuisen
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Circulation 2000;102(2):203-10.
2000: Catalin M Filipeanu; Adriaan Nelemans; Robert Jan Veldman; Dick De Zeeuw; Jan Willem Kok
Regulation of [Ca(2+)](i) homeostasis in MRP1 overexpressing cells.
FEBS letters 2000;474(1):107-10.
2000: P van Paassen; Dick De Zeeuw; gerjan navis; Paul E de Jong
Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(5):637-43.
2000: J Broekroelofs; gerjan navis; Coen A Stegeman; Wim van Der Bij; Wim J de Boer; Dick De Zeeuw; Paul E de Jong
Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss.
Transplantation 2000;69(8):1624-8.
2000: AC Teisman; Hendrik Buikema; Dirk J van Veldhuisen; Dick De Zeeuw; Wiek H van Gilst
Direct vasodilating effects of the new dopaminergic agonist Z1046 in human arteries.
Journal of cardiovascular pharmacology 2000;35(4):581-5.
2000: AC Teisman; Dirk J van Veldhuisen; Frans Boomsma; Pieter J de Kam; Geert Tjeerdsma; Yigal M Pinto; Dick De Zeeuw; Wiek H van Gilst
Chronic beta-blocker treatment in patients with advanced heart failure. Effects on neurohormones.
International journal of cardiology 2000;73(1):7-12; discussion 13-4.
2000: J Broekroelofs; Coen A Stegeman; gerjan navis; J de Haan; Wim van Der Bij; Wim J de Boer; Dick De Zeeuw; Paul E de Jong
Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable?
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(3):256-62.
2000: FH Wapstra; gerjan navis; Paul E de Jong; Dick De Zeeuw
Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Journal of the American Society of Nephrology : JASN 2000;11(3):490-6.
2000: AC Teisman; Ben H C Westerink; Dirk J van Veldhuisen; Egbert Scholtens; Dick De Zeeuw; Wiek H van Gilst
Direct interaction between the sympathetic and renin-angiotensin system in myocardial tissue: a microdialysis study in anaesthetised rats.
Journal of the autonomic nervous system 2000;78(2-3):117-21.
2000: Ron T Gansevoort; Dick De Zeeuw
The antihypertensive and renal effects of angiotensin II receptor antagonists: remaining questions.
Current opinion in nephrology and hypertension 2000;9(1):57-61.
1999: P van Paassen; gerjan navis; Paul E de Jong; Dick De Zeeuw
Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
European journal of clinical investigation 1999;29(12):1019-26.
1999: Eric De Boer; gerjan navis; Anton T M G Tiebosch; Paul E de Jong; Dick De Zeeuw
Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats.
Journal of the American Society of Nephrology : JASN 1999;10(11):2359-66.
1999: Anton J M Roks; Peter P van Geel; Yigal M Pinto; Hendrik Buikema; Robert H Henning; Dick De Zeeuw; Wiek H van Gilst
Angiotensin-(1-7) is a modulator of the human renin-angiotensin system.
Hypertension 1999;34(2):296-301.
1999: P A de Vries; gerjan navis; Paul E de Jong; Dick De Zeeuw; C Alex Kluppel
Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1999;34(2):191-8.
1999: Paul E de Jong; gerjan navis; Dick De Zeeuw
Renoprotective therapy: titration against urinary protein excretion.
Lancet 1999;354(9176):352-3.
1999: E de Boer; gerjan navis; FH Wapstra; Paul E de Jong; Dick De Zeeuw
Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable.
Kidney international. Supplement 1999;71():S42-6.
1999: FH Wapstra; H van Goor; Paul E de Jong; gerjan navis; Dick De Zeeuw
Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.
Journal of pharmacological and toxicological methods 1999;41(2-3):69-73.
1999: H Buter; gerjan navis; A J Woittiez; Dick De Zeeuw; Paul E de Jong
Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function.
European journal of clinical pharmacology 1999;54(12):953-8.
1999: Dirk K F Meijer; Guido J E J Hooiveld; A H Schinkel; Jessica E van Montfoort; Marijke Haas Jimoh Akanbi; Dick De Zeeuw; Frits Moolenaar; J W Smit; Peter J Meier Abt
Transport mechanisms for cationic drugs and proteins in kidney, liver and intestine: implication for drug interactions and cell-specific drug delivery.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14 Suppl 4():1-3.
1999: M H Hemmelder; Dick De Zeeuw; Paul E de Jong
Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(1):98-104.
1999: Robbert J Kok; F Grijpstra; R B Walthuis; Frits Moolenaar; Dick De Zeeuw; Dirk K F Meijer
Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme.
The Journal of pharmacology and experimental therapeutics 1999;288(1):281-5.
1998: T Tepper; W J Sluiter; Roel M Huisman; Dick De Zeeuw
Erythrocyte Na+/Li+ countertransport and Na+/K+-2Cl- co-transport measurement in essential hypertension: useful diagnostic tools or failure? A meta-analysis of 17 years of literature.
Clinical science (London, England : 1979) 1998;95(6):649-57.
1998: M H Hemmelder; P E de Jong; Dick De Zeeuw
A comparison of analytic procedures for measurement of fractional dextran clearances.
The Journal of laboratory and clinical medicine 1998;132(5):390-403.
1998: J Broekroelofs; Coen A Stegeman; gerjan navis; Adam M Tegzess; Dick De Zeeuw; Paul E de Jong
Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
Journal of the American Society of Nephrology : JASN 1998;9(11):2075-81.
1998: Marijke Haas Jimoh Akanbi; F Moolenaar; D K Meijer; Paul E de Jong; Dick De Zeeuw
Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.
Clinical science (London, England : 1979) 1998;95(5):603-9.
1998: H Buter; MH Hemmelder; gerjan navis; Paul E de Jong; Dick De Zeeuw
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(7):1682-5.
1998: Robbert J Kok; Marijke Haas Jimoh Akanbi; Frits Moolenaar; Dick De Zeeuw; Dirk K F Meijer
Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozyme.
Renal failure 1998;20(2):211-7.
1998: J Koiter; gerjan navis; Paul E de Jong; W H van Gilst; Dick De Zeeuw
Sample dilution: a methodological pitfall in the measurement of tissue but not serum ace-activity.
Journal of pharmacological and toxicological methods 1998;39(1):45-9.
1997: Marijke Haas Jimoh Akanbi; AC Kluppel; E S Wartna; Frits Moolenaar; Dirk K F Meijer; Paul E de Jong; Dick De Zeeuw
Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
Kidney international 1997;52(6):1693-9.
1997: H Buter; gerjan navis; Dick De Zeeuw; Paul E de Jong
Renal hemodynamic effects of candesartan in normal and impaired renal function in humans.
Kidney international. Supplement 1997;63():S185-7.
1997: G G van Essen; Alfred J Apperloo; Pieter L Rensma; Coen A Stegeman; W J Sluiter; Dick De Zeeuw; Paul E de Jong
Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
Kidney international. Supplement 1997;63():S58-62.
1997: Frank G H van Der Kleij; A Schmidt; gerjan navis; M Haas; N Yilmaz; Paul E de Jong; G Mayer; Dick De Zeeuw
Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
Kidney international. Supplement 1997;63():S23-6.
1997: Catalin M Filipeanu; Dick De Zeeuw; S Adriaan Nelemans
Delta9-tetrahydrocannabinol activates [Ca2+]i increases partly sensitive to capacitative store refilling.
European journal of pharmacology 1997;336(1):R1-3.
1997: Marijke Haas Jimoh Akanbi; AC Kluppel; Frits Moolenaar; Dirk K F Meijer; Paul E de Jong; Dick De Zeeuw
Urine collection in the freely moving rat: reliability for measurement of short-term renal effects.
Journal of pharmacological and toxicological methods 1997;38(1):47-51.
1997: Dick De Zeeuw; Giuseppe Remuzzi; W Kirch
Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.
Journal of human hypertension 1997;11 Suppl 2():S37-42.
1997: gerjan navis; Dick De Zeeuw; Paul E de Jong
ACE-inhibitors: panacea for progressive renal disease.
Lancet 1997;349(9069):1852-3.
1997: Marijke Haas Jimoh Akanbi; Frits Moolenaar; AC Kluppel; D Dijkstra; Dirk K F Meijer; Dick De Zeeuw
Determination of dopaminergic prodrugs by high-performance liquid chromatography followed by post-column ion-pair extraction.
Journal of chromatography. B, Biomedical sciences and applications 1997;693(2):484-8.
1997: Robbert J Kok; Jan Visser; Frits Moolenaar; Dick De Zeeuw; Dirk K F Meijer
Bioanalysis of captopril: two sensitive high-performance liquid chromatographic methods with pre- or postcolumn fluorescent labeling.
Journal of chromatography. B, Biomedical sciences and applications 1997;693(1):181-9.
1997: Ron T Gansevoort; gerjan navis; F H Wapstra; Paul E de Jong; Dick De Zeeuw
Proteinuria and progression of renal disease: therapeutic implications.
Current opinion in nephrology and hypertension 1997;6(2):133-40.
1997: Alfred J Apperloo; Dick De Zeeuw; Paul E de Jong
A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function.
Kidney international 1997;51(3):793-7.
1997: gerjan navis; Paul E de Jong; Dick De Zeeuw
Optimizing the renal response to ace inhibition: a strategy toward more effective long-term renoprotection.
Advances in nephrology from the Necker Hospital 1997;27():57-66.
1997: MH Hemmelder; Dick De Zeeuw; Paul E de Jong
Measurement of glomerular charge selectivity in non-diabetic renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():57-62.
1997: H Buter; MH Hemmelder; P van Paassen; gerjan navis; Dick De Zeeuw; Paul E de Jong
Is the antiproteinuric response to inhibition of the renin-angiotensin system less effective during the night?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():53-6.
1997: Frank G H van Der Kleij; gerjan navis; Ron T Gansevoort; J E Heeg; H Scheffer; Dick De Zeeuw; Paul E de Jong
ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():42-6.
1997: gerjan navis; H Buter; Paul E de Jong; R P F Dullaart; Dick De Zeeuw
Effect of antiproteinuric treatment on the lipid profile in nondiabetic renal disease.
Contributions to nephrology 1997;120():88-96.
1996: W M Janssen; Paul E de Jong; Dick De Zeeuw
Hypertension and renal disease: role of microalbuminuria.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1996;14(5):S173-7.
1996: gerjan navis; Dick De Zeeuw
Titrating for antiproteinuric effect: the clue to renoprotection?
Journal of human hypertension 1996;10(10):669-73.
1996: C A Visscher; Dick De Zeeuw; gerjan navis; A K Van Zanten; Paul E de Jong; Roel M Huisman
Renal 131I-hippurate clearance overestimates true renal blood flow in the instrumented conscious dog.
The American journal of physiology 1996;271(2 Pt 2):F269-74.
1996: R P F Dullaart; Ron T Gansevoort; W J Sluiter; Dick De Zeeuw; Paul E de Jong
The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment.
Metabolism: clinical and experimental 1996;45(6):723-30.
1996: F H Wapstra; H Van Goor; gerjan navis; Paul E de Jong; Dick De Zeeuw
Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
Clinical science (London, England : 1979) 1996;90(5):393-401.
1996: A J Apperloo; Dick De Zeeuw; A J M Donker; Paul E de Jong
Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran.
Journal of the American Society of Nephrology : JASN 1996;7(4):567-72.
1996: C A Visscher; Dick De Zeeuw; Paul E de Jong; D A Piers; H Beekhuis; G M Groothuis; Roel M Huisman
Angiotensin-converting enzyme inhibition-induced changes in hippurate renography and renal function in renovascular hypertension.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(3):482-8.
1996: P van Paassen; Dick De Zeeuw; gerjan navis; Paul E de Jong
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
Hypertension 1996;27(2):202-8.
1996: G G van Essen; P L Rensma; Dick De Zeeuw; W J Sluiter; H Scheffer; A J Apperloo; Paul E de Jong
Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy.
Lancet 1996;347(8994):94-5.
1996: F H Wapstra; gerjan navis; Paul E de Jong; Dick De Zeeuw
Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease.
Experimental nephrology 1996;4 Suppl 1():47-52.
1996: M H Hemmelder; Dick De Zeeuw; Ron T Gansevoort; Paul E de Jong
Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition.
Kidney international 1996;49(1):174-80.
1995: Ron T Gansevoort; W J Sluiter; M H Hemmelder; Dick De Zeeuw; Paul E de Jong
Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(11):1963-74.
1995: C A Visscher; Dick De Zeeuw; Paul E de Jong; W J Sluiter; Roel M Huisman
Drug-induced changes in renal hippurate clearance as a measure of renal blood flow.
Kidney international 1995;48(5):1617-23.
1995: W M Janssen; H Beekhuis; R de Bruin; Paul E de Jong; Dick De Zeeuw
Noninvasive measurement of intrarenal blood flow distribution: kinetic model of renal 123I-hippuran handling.
The American journal of physiology 1995;269(4 Pt 2):F571-80.
1995: Dick De Zeeuw; Ron T Gansevoort; Paul E de Jong
Losartan in patients with renal insufficiency.
The Canadian journal of cardiology 1995;11 Suppl F():41F-44F.
1995: Dick De Zeeuw; Ron T Gansevoort; R P F Dullaart; Paul E de Jong
Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(1):S53-8.
1995: M H Hemmelder; Dick De Zeeuw; Vaclav Fidler; Paul E de Jong
Proteinuria: a risk factor for pregnancy-related renal function decline in primary glomerular disease?
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(1):187-92.
1995: P van Paassen; Dick De Zeeuw; Paul E de Jong
Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
Journal of cardiovascular pharmacology 1995;26(1):39-45.
1995: C A Visscher; Dick De Zeeuw; Roel M Huisman
Effect of chronic ACE inhibition on the diagnostic value of renography for renovascular hypertension: a preliminary report.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(2):263-5.
1995: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(4):497-504.
1994: A J Apperloo; Dick De Zeeuw; Paul E de Jong
Discordant effects of enalapril and lisinopril on systemic and renal hemodynamics.
Clinical pharmacology and therapeutics 1994;56(6 Pt 1):647-58.
1994: Ron T Gansevoort; Dick De Zeeuw; S Shahinfar; A Redfield; Paul E de Jong
Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(2):S37-42.
1994: W M Janssen; Dick De Zeeuw; G K van der Hem; Paul E de Jong
Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Journal of hypertension 1994;12(4):439-47.
1994: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
Kidney international 1994;45(3):861-7.
1994: A J Apperloo; Dick De Zeeuw; Paul E de Jong
Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease.
Kidney international. Supplement 1994;45():S174-8.
1994: Ron T Gansevoort; J E Heeg; F D Dikkeschei; Dick De Zeeuw; Paul E de Jong; R P F Dullaart
Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(3):244-50.
1993: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition.
Kidney international 1993;44(3):579-84.
1993: E J Franssen; Frits Moolenaar; Dick De Zeeuw; Dirk K F Meijer
Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid.
Pharmaceutical research 1993;10(7):963-9.
1993: R P F Dullaart; Ron T Gansevoort; B D Dikkeschei; Dick De Zeeuw; Paul E de Jong; Arie Van Tol
Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients.
Kidney international 1993;44(1):91-7.
1993: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(1):202-6.
1993: Dick De Zeeuw; R T Gansevoort; P E de Jong
Have rational therapeutic principles emerged in treating hypertension in chronic renal failure?
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;21(5 Suppl 2):108-12.
1993: Marijke Haas Jimoh Akanbi; Dick De Zeeuw; A van Zanten; D K Meijer
Quantification of renal low-molecular-weight protein handling in the intact rat.
Kidney international 1993;43(4):949-54.
1993: E J Franssen; Frits Moolenaar; Dick De Zeeuw; Dirk K F Meijer
Low-molecular-weight proteins as carriers for renal drug targeting.
Contributions to nephrology 1993;101():99-103.
1993: G J Jonker; Roel M Huisman; Dick De Zeeuw
Enhancement of screening tests for renovascular hypertension by angiotensin-converting enzyme inhibition.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1993;8(9):798-807.
1993: Marijke Haas Jimoh Akanbi; Dick De Zeeuw; Dirk K F Meijer
Quantification of renal low-molecular-weight protein degradation in the intact rat.
Contributions to nephrology 1993;101():78-84.
1992: T Tepper; J F Jilderda; Roel M Huisman; G K van der Hem; Dick De Zeeuw
Differences in erythrocyte sodium transport between human plasma and artificial medium: the role and character of sodium efflux and influx stimulating plasma factors.
Clinica chimica acta; international journal of clinical chemistry 1992;213(1-3):61-73.
1992: Frits Moolenaar; S Crancrinus; J Visser; Dick De Zeeuw; Dirk K F Meijer
Clearance of indomethacin occurs predominantly by renal glucuronidation.
Pharmaceutisch weekblad. Scientific edition 1992;14(4):191-5.
1992: W M Janssen; Dick De Zeeuw; G K van der Hem; Paul E de Jong
Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
Hypertension 1992;20(1):80-4.
1992: E J Franssen; J Koiter; C A Kuipers; A P Bruins; Frits Moolenaar; Dick De Zeeuw; W H Kruizinga; R M Kellogg; Dirk K F Meijer
Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
Journal of medicinal chemistry 1992;35(7):1246-59.
1992: Ron T Gansevoort; F H Wapstra; J J Weening; Paul E de Jong; Dick De Zeeuw
Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis.
Nephron 1992;60(2):246-7.
1992: G J Jonker; C A Visscher; Dick De Zeeuw; Roel M Huisman; D A Piers; H Beekhuis; G K van der Hem
Changes in renal function induced by ACE-inhibition in the conscious two-kidney, one-clip Goldblatt hypertensive dog.
Nephron 1992;60(2):226-31.
1992: Paul E de Jong; J E Heeg; A J Apperloo; Dick De Zeeuw
The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics.
Journal of cardiovascular pharmacology 1992;19 Suppl 6():S28-32.
1992: Ron T Gansevoort; J E Heeg; R Vriesendorp; Dick De Zeeuw; Paul E de Jong
Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7 Suppl 1():91-6.
1992: C A Visscher; Roel M Huisman; H Beekhuis; D B Piers; Dick De Zeeuw
Influence of anaesthesia on renal hippurate handling during angiotensin-converting enzyme inhibition in unilateral renal artery stenosis.
American journal of nephrology 1992;12(6):474-6.
1991: Dick De Zeeuw; G J Jonker; T K Hovinga; H Beekhuis; D A Piers; Roel M Huisman; Paul E de Jong
The mechanism and diagnostic value of angiotensin I converting enzyme inhibition renography.
American journal of hypertension 1991;4(12 Pt 2):741S-744S.
1991: A J Apperloo; Dick De Zeeuw; H E Sluiter; Paul E de Jong
Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease.
BMJ (Clinical research ed.) 1991;303(6806):821-4.
1991: E J Franssen; R G van Amsterdam; J Visser; Frits Moolenaar; Dick De Zeeuw; Dirk K F Meijer
Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.
Pharmaceutical research 1991;8(10):1223-30.
1991: J E Heeg; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.
Kidney international 1991;40(4):734-41.
1991: J E Heeg; Paul E de Jong; Dick De Zeeuw
Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.
Clinical science (London, England : 1979) 1991;81(3):367-72.
1991: Paul E de Jong; J E Heeg; A J Apperloo; Dick De Zeeuw
Angiotensin-I converting enzyme inhibition: clinical effects in chronic renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;17(5 Suppl 1):85-8.
1990: J E Heeg; Paul E de Jong; R Vriesendorp; Dick De Zeeuw
Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.
American journal of nephrology 1990;10 Suppl 1():94-7.
1990: Paul E de Jong; A J Apperloo; J E Heeg; Dick De Zeeuw
Lisinopril in hypertensive patients with renal function impairment.
Nephron 1990;55 Suppl 1():43-8.
1990: T K Kremer Hovinga; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Relief of renal artery stenosis: a tool to improve or preserve renal function in renovascular disease?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(7):481-8.
1990: Dick De Zeeuw; J E Heeg; T Stelwagen; R J de Jong; Paul E de Jong
Mechanism of the antiproteinuric effect of angiotensin-converting enzyme inhibition.
Contributions to nephrology 1990;83():160-5.
1989: J E Heeg; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
Kidney international 1989;36(2):272-9.
1989: W M Janssen; Dick De Zeeuw; G K van der Hem; Paul E de Jong
Atrial natriuretic peptide-induced decreases in renal blood flow in man: implications for the natriuretic mechanism.
Clinical science (London, England : 1979) 1989;77(1):55-60.
1989: W M Janssen; Dick De Zeeuw; G K van der Hem; Paul E de Jong
Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans.
Hypertension 1989;13(6 Pt 1):640-6.
1989: T K Kremer Hovinga; Paul E de Jong; D A Piers; H Beekhuis; G K van der Hem; Dick De Zeeuw
Diagnostic use of angiotensin converting enzyme inhibitors in radioisotope evaluation of unilateral renal artery stenosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(5):605-14.
1989: T Tepper; Roel M Huisman; J F Jilderda; G K van der Hem; Dick De Zeeuw
Human plasma contains low molecular weight factors which stimulate active sodium transport in erythrocytes.
Clinica chimica acta; international journal of clinical chemistry 1989;179(2):133-42.
1988: G J Jonker; Dick De Zeeuw; Roel M Huisman; G K van der Hem
Angiotensin converting enzyme inhibition induces alterations to hippuran renography despite unchanged ipsilateral renal blood flow in conscious two-kidney, one clip Goldblatt hypertensive dogs.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S455-7.
1988: G J Jonker; Dick De Zeeuw; Roel M Huisman; D B Piers; H Beekhuis; G K van der Hem
Angiotensin converting enzyme inhibition improves diagnostic procedures for renovascular hypertension in dogs.
Hypertension 1988;12(4):411-9.
1988: W M Janssen; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Involvement of atrial natriuretic peptide in long-term regulation of sodium-homeostasis in man.
Clinical nephrology 1988;30(3):172.
1988: Dick De Zeeuw; D C Brater; H R Jacobson
Micro-HPLC and transfer techniques for directly measuring drug (indomethacin) transport across the isolated perfused renal proximal straight tubule.
Journal of pharmacological methods 1988;19(4):275-82.
1988: G J Jonker; Dick De Zeeuw; Roel M Huisman; G K van der Hem
A new constrictor device for external induction of a long-term stable and irreversible renal artery stenosis in the dog.
Pflügers Archiv : European journal of physiology 1988;411(6):688-91.
1988: Dick De Zeeuw; H R Jacobson; D C Brater
Indomethacin secretion in the isolated perfused proximal straight rabbit tubule. Evidence for two parallel transport mechanisms.
The Journal of clinical investigation 1988;81(5):1585-92.
1988: Dick De Zeeuw; R Tomasini; Marijke Haas Jimoh Akanbi; Paul E de Jong; J J Weening; G K van der Hem
Effect of mild charge modification of albumin on renal excretion in the rat.
Contributions to nephrology 1988;68():121-7.
1988: Paul E de Jong; J van der Meer; G K van der Hem; Dick De Zeeuw
Is the antiproteinuric effect of dipyridamole hemodynamically mediated?
Nephron 1988;50(4):292-4.
1987: J E Heeg; Paul E de Jong; G K van der Hem; Dick De Zeeuw
Reduction of proteinuria by angiotensin converting enzyme inhibition.
Kidney international 1987;32(1):78-83.
1986: T K Hovinga; Paul E de Jong; Dick De Zeeuw; K H Schuur; G K Van der Hem
Short-term effects of percutaneous transluminal renal angioplasty on renal function in unilateral renal artery stenosis.
The Netherlands journal of medicine 1986;29(11):347-51.
1986: T K Kremer Hovinga; Paul E de Jong; Dick De Zeeuw; A J Donker; K H Schuur; G K van der Hem
Restenosis prevalence and long-term effects on renal function after percutaneous transluminal renal angioplasty.
Nephron 1986;44 Suppl 1():64-7.
1985: T Tepper; J F Jilderda; Roel M Huisman; Dick De Zeeuw; G K van der Hem
Semi-micro method for the determination of cation flux rate constants in erythrocytes.
Clinica chimica acta; international journal of clinical chemistry 1985;150(2):137-49.
1985: G J Jonker; Dick De Zeeuw; Roel M Huisman; G K van der Hem
Pharmacological zero for electromagnetic renal blood flow measurement.
Pflügers Archiv : European journal of physiology 1985;403(2):220-1.
1983: Dick De Zeeuw; J F Jilderda; T Tepper
Erythrocyte sodium-potassium co-transport in hypertension.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1983;20():507-13.
1983: K J Kuiper; Paul E de Jong; Dick De Zeeuw; K H Schuur; G K van der Hem
Restenosis of the renal artery after percutaneous transluminal renal angioplasty: an inevitable outcome?
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1983;20():538-45.
1983: Paul E de Jong; Dick De Zeeuw; A J Smit; S J Hoorntje; K H Schuur; A J Donker; G K Van der Hem
The effect of transluminal dilation of stenosed renal arteries on kidney function.
The Netherlands journal of medicine 1983;26(9):266-70.